Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IB”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT04825392
What this trial is testing

A Phase Ib Study of HX008 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Taizhou Hanzhong biomedical co. LTD 30
Early research (Phase 1)Active Not RecruitingNCT04520711
What this trial is testing

Hotspot TCR-T: A Phase I/Ib Study of Adoptively Transferred T-cell Receptor Gene-engineered T Cells (TCR-T)

Who this might be right for
Malignant Epithelial Neoplasms
Providence Health & Services 24
Testing effectiveness (Phase 2)Study completedNCT01402271
What this trial is testing

Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
European Organisation for Research and Treatment of Cancer - EORTC 88
Early research (Phase 1)Study completedNCT03579628
What this trial is testing

AsiDNA (a DNA Repair Inhibitor) Administered IntraVenously in Advanced Solid Tumors

Who this might be right for
Advanced Cancer
Valerio Therapeutics 33
Early research (Phase 1)Study completedNCT03111992
What this trial is testing

Study of Single Agent CJM112, and PDR001 in Combination With LCL161 or CJM112 in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Novartis Pharmaceuticals 26
Early research (Phase 1)Study completedNCT00375245
What this trial is testing

Rapamycin With Grapefruit Juice for Advanced Malignancies

Who this might be right for
TumorsNeoplasm Metastasis
University of Chicago 41
Early research (Phase 1)Looking for participantsNCT07256301
What this trial is testing

A Phase Ib, Multicenter, Open-Label Study of Multiple-Dose EA5 in Adults With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Who this might be right for
PNH - Paroxysmal Nocturnal Hemoglobinuria
Shanghai Lanyi Therapeutics Co., Ltd. 24
Early research (Phase 1)Looking for participantsNCT06969612
What this trial is testing

A Study on the Efficacy and Safety of Golidocitinib Combined With Tislelizumab and Chemotherapy as First-line Treatment for Advanced NSCLC

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)
Peking University Cancer Hospital & Institute 21
Large-scale testing (Phase 3)Study completedNCT01547741
What this trial is testing

Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 4,242
Early research (Phase 1)Ended earlyNCT04000529
What this trial is testing

Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies

Who this might be right for
Non-small Cell Lung CarcinomaHead and Neck Squamous Cell CarcinomaEsophageal SCC+2 more
Novartis Pharmaceuticals 122
Early research (Phase 1)Active Not RecruitingNCT07557004
What this trial is testing

SH3765 Tablets in Combination With Fulvestrant in Patients With HR+/HER2- Advanced Breast Cancer.

Who this might be right for
HR+ / HER2- Advanced Breast Cancer
Nanjing Sanhome Pharmaceutical, Co., Ltd. 30
Early research (Phase 1)Looking for participantsNCT06418061
What this trial is testing

Study of IBI3005 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors

Who this might be right for
UnresectableLocally Advanced or Metastatic Solid Tumors
Innovent Biologics (Suzhou) Co. Ltd. 198
Testing effectiveness (Phase 2)Study completedNCT00439660
What this trial is testing

Dose Escalation Study to Evaluate Oral Rotavirus Vaccine 116E Live Attenuated in Healthy Infants 8 to 20 Weeks Old

Who this might be right for
Diarrhea
Bharat Biotech International Limited 540
Early research (Phase 1)Study completedNCT04171791
What this trial is testing

ABT-199 (Venetoclax) for Cutaneous T Cell Lymphoma (CTCL)

Who this might be right for
CTCL
Yale University 4
Testing effectiveness (Phase 2)WithdrawnNCT02522910
What this trial is testing

An Open-label Phase Ib/II Study of BAY 1000394 (Roniciclib) in Combination With Docetaxel in Second- or Third-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
NSCLC (Non-Small Cell Lung Cancer)
Yonsei University
Testing effectiveness (Phase 2)Looking for participantsNCT07111520
What this trial is testing

A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
BioNTech SE 880
Testing effectiveness (Phase 2)Looking for participantsNCT05133882
What this trial is testing

A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML

Who this might be right for
Acute Myeloid Leukemia, Adult
Sunshine Lake Pharma Co., Ltd. 133
Early research (Phase 1)Ended earlyNCT06193174
What this trial is testing

Re-Administration of C134 in Patients With Recurrent GBM (C134-HSV-1)

Who this might be right for
Recurrent Malignant GliomaGlioblastoma Multiforme of BrainGliosarcoma of Brain+1 more
University of Alabama at Birmingham 1
Early research (Phase 1)Study completedNCT04088890
What this trial is testing

Autologous CD22 CAR T Cells in Adults w/ Recurrent or Refractory B Cell Malignancies

Who this might be right for
B-ALLB-cell Non Hodgkin LymphomaDLBCL+1 more
Matthew Frank 52
Early research (Phase 1)Study completedNCT01540760
What this trial is testing

MCAF5352A in Healthy Volunteers

Who this might be right for
Healthy Volunteer
Genentech, Inc. 23
Next Page